Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-25 @ 9:11 PM
Study NCT ID:
NCT04632056
Status:
COMPLETED
Last Update Posted:
2023-11-14
First Post:
2020-11-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-12
First Submit QC Date:
None
Study First Post Date:
2020-11-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-10
Last Update Post Date:
2023-11-14
Last Update Post Date Type:
ACTUAL